Skip to main content
Fig. 5 | Radiation Oncology

Fig. 5

From: Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment

Fig. 5

Cumulative incidence function for secondary tumors revealed no significant intermodality difference between incidences of secondary malignanciesfor patients treated with definitive concurrent radiochemotherapy (RCTx 1) compared to those treated with neoadjuvant radiochemotherapy followed by surgery (trimodal 2) (p = 0.4352, Gray’s test)

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us